Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Deficiency”

46 trials

Showing 20 of 46 results

Not applicableNot Yet RecruitingNCT07476222
What this trial is testing

Predictors of Androgen Status Decline in Middle-Aged Men

Who this might be right for
Testosterone DeficiencyAndrogen DeficiencyMale Hypogonadism+1 more
Andijan State Medical Institute 600
Not applicableLooking for participantsNCT00250159
What this trial is testing

Natural History Study of Patients With Excess Androgen

Who this might be right for
Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT03522064
What this trial is testing

Bipolar Androgen Therapy + Carboplatin in mCRPC

Who this might be right for
Castration-resistant Prostate CancerHomologous Recombination Deficiency
St Vincent's Hospital, Sydney 30
Early research (Phase 1)Study completedNCT03967964
What this trial is testing

Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

Who this might be right for
PharmacokineticsHormone Deficiency
Laboratorios Andromaco S.A. 46
Testing effectiveness (Phase 2)Study completedNCT03716739
What this trial is testing

Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 136
Not applicableUnknownNCT04710186
What this trial is testing

AR, IGF-IR, IR and Peripheral Artery Disease

Who this might be right for
Androgen Receptor AbnormalInsulin-Like Growth Factor I DeficiencyInsulin Receptor, Defect in
University of Catanzaro 30
Testing effectiveness (Phase 2)Study completedNCT00006158
What this trial is testing

AIDS Wasting in Women: Anabolic Effects of Testosterone

Who this might be right for
AIDS Wasting Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00398580
What this trial is testing

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men

Who this might be right for
HypogonadismHypogonadism, Male
GlaxoSmithKline 43
Early research (Phase 1)Study completedNCT00400335
What this trial is testing

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Who this might be right for
HypogonadismHypogonadism, Male
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT00185198
What this trial is testing

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Who this might be right for
Androgens (Deficiency)Male
Bayer 363
Not applicableUnknownNCT00150163
What this trial is testing

Odense Androgen Study: Study of Androgens, Body Composition, and Muscle Function in Danish Men

Who this might be right for
Bone Diseases
Odense University Hospital 800
Testing effectiveness (Phase 2)WithdrawnNCT03548246
What this trial is testing

Androgen Reduction in Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT03306745
What this trial is testing

Micronutrient Supplementation in PCO-syndrome

Who this might be right for
Polycystic Ovary SyndromeInfertility, FemaleMicronutrient Deficiency
Medical University of Vienna 60
Early research (Phase 1)Study completedNCT00540553
What this trial is testing

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

Who this might be right for
Healthy SubjectsAndrogen Deficiency
GlaxoSmithKline 126
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Post-approval studies (Phase 4)Study completedNCT00194675
What this trial is testing

TRADE-Testosterone Replacement and Dutasteride Effectiveness

Who this might be right for
HypogonadismBenign Prostatic Hyperplasia
University of Washington 53
Large-scale testing (Phase 3)WithdrawnNCT05098327
What this trial is testing

Pioglitazone and Insulin Resistance in ADT

Who this might be right for
Prostate CancerInsulin ResistanceDiabetes Mellitus, Type 2+1 more
State University of New York at Buffalo
Testing effectiveness (Phase 2)WithdrawnNCT02147964
What this trial is testing

ITT-5 Mechanisms of Spermatogenesis in Man

Who this might be right for
Gonadotropin Deficiency
University of Washington
Not applicableStudy completedNCT00858650
What this trial is testing

Registry of Hypogonadism in Men

Who this might be right for
Male HypogonadismAndrogen DeficiencyTestosterone Deficiency
Carelon Research 999
Large-scale testing (Phase 3)Study completedNCT00161304
What this trial is testing

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

Who this might be right for
Men With Low Testosterone Levels
Leonard S. Marks, M.D. 44
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation